Tonix Pharmaceuticals (TNXP) Announces Completion of Phase 3 AFFIRM Enrollment
Tweet Send to a Friend
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) announced that it has completed enrollment in its Phase 3 AFFIRM clinical trial of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
